1. Home
  2. HALO vs CTRE Comparison

HALO vs CTRE Comparison

Compare HALO & CTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HALO
  • CTRE
  • Stock Information
  • Founded
  • HALO 1998
  • CTRE 2013
  • Country
  • HALO United States
  • CTRE United States
  • Employees
  • HALO N/A
  • CTRE N/A
  • Industry
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • CTRE Real Estate Investment Trusts
  • Sector
  • HALO Health Care
  • CTRE Real Estate
  • Exchange
  • HALO Nasdaq
  • CTRE Nasdaq
  • Market Cap
  • HALO 9.0B
  • CTRE 7.5B
  • IPO Year
  • HALO N/A
  • CTRE N/A
  • Fundamental
  • Price
  • HALO $65.56
  • CTRE $34.51
  • Analyst Decision
  • HALO Buy
  • CTRE Buy
  • Analyst Count
  • HALO 10
  • CTRE 5
  • Target Price
  • HALO $73.40
  • CTRE $35.00
  • AVG Volume (30 Days)
  • HALO 2.2M
  • CTRE 2.2M
  • Earning Date
  • HALO 10-30-2025
  • CTRE 10-28-2025
  • Dividend Yield
  • HALO N/A
  • CTRE 3.88%
  • EPS Growth
  • HALO 68.93
  • CTRE 108.23
  • EPS
  • HALO 4.37
  • CTRE 1.21
  • Revenue
  • HALO $1,178,672,000.00
  • CTRE $373,415,000.00
  • Revenue This Year
  • HALO $32.57
  • CTRE $18.92
  • Revenue Next Year
  • HALO $23.25
  • CTRE $26.91
  • P/E Ratio
  • HALO $15.12
  • CTRE $28.56
  • Revenue Growth
  • HALO 34.97
  • CTRE 50.83
  • 52 Week Low
  • HALO $42.01
  • CTRE $24.79
  • 52 Week High
  • HALO $79.50
  • CTRE $35.68
  • Technical
  • Relative Strength Index (RSI)
  • HALO 31.20
  • CTRE 52.04
  • Support Level
  • HALO $73.06
  • CTRE $34.07
  • Resistance Level
  • HALO $76.30
  • CTRE $35.68
  • Average True Range (ATR)
  • HALO 2.33
  • CTRE 0.64
  • MACD
  • HALO -1.57
  • CTRE -0.00
  • Stochastic Oscillator
  • HALO 3.81
  • CTRE 40.00

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About CTRE CareTrust REIT Inc.

CareTrust REIT Inc is a self-administered, publicly-traded REIT engaged in the ownership, acquisition, financing, development and leasing of skilled nursing, seniors housing and other healthcare-related properties. The company has one reportable segment consisting of investments in healthcare-related real estate assets. It generates revenues by leasing healthcare-related properties to healthcare operators in triple-net lease arrangements, under which the tenant is solely responsible for the costs related to the property.

Share on Social Networks: